You are here

Studies Suggest Possible Link of Neuromyelitis Optica Diagnosis After COVID-19 Vaccination

Studies Suggest Possible Link of Neuromyelitis Optica Diagnosis After COVID-19 Vaccination | 19 June 2022 | Emergent peer-reviewed studies have highlighted the occurrence of neuromyelitis optica after COVID-19 vaccinations, suggesting that the autoimmune disease may be occurring as a vaccine adverse event. The studies' general findings indicate an occurrence of neuromyelitis optica (NMO) in healthy individuals within around two weeks after Pfizer, Moderna, and AstraZeneca vaccines. In patients already affected by the disease or a similar neurological autoimmune disease such as multiple sclerosis, an exacerbation of symptoms or relapse was observed. Neuromyelitis optica is a rare autoimmune disease in which the immune system mistakenly attacks the spinal cord and the nerves in the eyes... So far, at least six cases of NMO occurring after COVID-19 vaccination have been reported in case studies around the world.